- Home
- PLCE vs STRO Comparison
PLCE vs STRO Comparison
Compare PLCE & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLCE
- STRO
- Stock Information
- Founded
- PLCE 1969
- STRO 2003
- Country
- PLCE United States
- STRO United States
- Employees
- PLCE N/A
- STRO N/A
- Industry
- PLCE Clothing/Shoe/Accessory Stores
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLCE Consumer Discretionary
- STRO Health Care
- Exchange
- PLCE Nasdaq
- STRO Nasdaq
- Market Cap
- PLCE 128.9M
- STRO 77.7M
- IPO Year
- PLCE 1997
- STRO 2018
- Fundamental
- Price
- PLCE $5.76
- STRO $0.90
- Analyst Decision
- PLCE Hold
- STRO Hold
- Analyst Count
- PLCE 1
- STRO 7
- Target Price
- PLCE $9.00
- STRO $5.47
- AVG Volume (30 Days)
- PLCE 411.4K
- STRO 1.2M
- Earning Date
- PLCE 06-11-2025
- STRO 05-08-2025
- Dividend Yield
- PLCE N/A
- STRO N/A
- EPS Growth
- PLCE N/A
- STRO N/A
- EPS
- PLCE N/A
- STRO N/A
- Revenue
- PLCE $1,386,269,000.00
- STRO $66,434,000.00
- Revenue This Year
- PLCE N/A
- STRO N/A
- Revenue Next Year
- PLCE N/A
- STRO N/A
- P/E Ratio
- PLCE N/A
- STRO N/A
- Revenue Growth
- PLCE N/A
- STRO N/A
- 52 Week Low
- PLCE $4.77
- STRO $0.52
- 52 Week High
- PLCE $19.74
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- PLCE 45.87
- STRO 50.82
- Support Level
- PLCE $5.60
- STRO $0.86
- Resistance Level
- PLCE $6.40
- STRO $0.99
- Average True Range (ATR)
- PLCE 0.37
- STRO 0.09
- MACD
- PLCE 0.03
- STRO 0.00
- Stochastic Oscillator
- PLCE 13.22
- STRO 68.44
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.